Author: Goss G.
Publisher: Elsevier
ISSN: 1359-6349
Source: EJC Supplements, Vol.1, Iss.8, 2003-10, pp. : 29-33
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Clinical benefit in NSCLC: the evidence for gefitinib ('Iressa', ZD1839)
By Lynch T.
EJC Supplements, Vol. 1, Iss. 8, 2003-10 ,pp. :
By Hiscox Stephen Morgan Liam Barrow Denise Dutkowski Carol Wakeling Alan Nicholson Robert
Clinical and Experimental Metastasis, Vol. 21, Iss. 3, 2004-05 ,pp. :